Early Detection and Interception of Lung Cancer.

Hematol Oncol Clin North Am

Department of Medicine, Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. Electronic address:

Published: August 2024

AI Article Synopsis

Article Abstract

Recent advances in lung cancer treatment have led to dramatic improvements in 5-year survival rates. And yet, lung cancer remains the leading cause of cancer-related mortality, in large part, because it is often diagnosed at an advanced stage, when cure is no longer possible. Lung cancer screening (LCS) is essential for intercepting the disease at an earlier stage. Unfortunately, LCS has been poorly adopted in the United States, with less than 5% of eligible patients being screened nationally. This article will describe the data supporting LCS, the obstacles to LCS implementation, and the promising opportunities that lie ahead.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2024.03.004DOI Listing

Publication Analysis

Top Keywords

lung cancer
16
early detection
4
detection interception
4
lung
4
interception lung
4
cancer
4
cancer advances
4
advances lung
4
cancer treatment
4
treatment led
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!